Latest Intravenous immunoglobulin Stories
BARCELONA, Spain, June 2 /PRNewswire/ -- Grifols, SA, a global healthcare company focused on clinical applications of human plasma proteins, announced at its annual meeting with investors and analysts, that it will initiate a new clinical investigation of Alzheimer's Disease in January 2011 with an anticipated enrollment of over 300 patients.
KING OF PRUSSIA, Pa., April 19 /PRNewswire/ -- CSL Behring announced today that the U.S.
RESEARCH TRIANGLE PARK, N.C., April 12 /PRNewswire-FirstCall/ -- Talecris Biotherapeutics, Inc., today announced results of a new survey showing that GamunexÂ® (Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified) is the preferred immune globulin intravenous (IGIV) among neurologists who indicated a brand preference.
LACHEN, Switzerland, February 16 /PRNewswire/ -- - Octapharma to Set New Standards in IVIG Development, Focused on Improving Outcomes For Patients and Physicians Octapharma AG today announced the start of the first of a series of Phase III studies for its new 10% high purity intravenous immunoglobulin (IVIG). The study will investigate the efficacy and safety of this novel immunoglobulin in the treatment of primary immune deficiency and, together with results from additional...
LACHEN, SWITZERLAND and HOBOKEN, N.J., Sept. 23 /PRNewswire/ -- Octapharma AG recently submitted its Biological License Application for octagam(R) 10% (human normal intravenous immunoglobulin, liquid) to the U.S.
AUSTIN, Texas, Aug.
Intravenous immunoglobulin (IVIg) treatments, the introduction of good antibodies into the blood stream, may hold promise for lowering the risk of Alzheimer's disease and other similar brain disorders, according to a new study.
California Assemblymember Mary Hayashi Calls on California Congressional Delegation to Remember Needs of Neuropathy Patients at 3rd Annual "Neuropathy Action Awareness Day" SACRAMENTO, Calif., June 25 /PRNewswire/ -- As President Obama continues his push for national health care reform, more than 300 neuropathy patients, physicians and medical professionals gathered in Sacramento today to call on Congress to restore access to life-sustaining and lifesaving treatments for neuropathy patients.
New research from Jefferson Hospital for Neuroscience (JHN) may redefine how Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is diagnosed. Eduardo De Sousa, M.D., assistant professor of Neurology at Jefferson Medical College of Thomas Jefferson University, and director of the Electrodiagnostic Neuromuscular Lab at JHN
LAS VEGAS and TOWSON, Md., May 11 /PRNewswire-USNewswire/ -- Founder and president of the Immune Deficiency Foundation (IDF), Marcia Boyle, traveled to Las Vegas this weekend to recognize the Cerda family, Wright Custom Home and many other community volunteers, for their efforts in raising awareness of primary immunodeficiency diseases (PIDD).
- A person in a secondary role, specifically the second most important character (after the protagonist).